1. Home
  2. OFIX vs MYGN Comparison

OFIX vs MYGN Comparison

Compare OFIX & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

HOLD

Current Price

$15.15

Market Cap

622.1M

Sector

Health Care

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.12

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFIX
MYGN
Founded
1987
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
622.1M
625.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
OFIX
MYGN
Price
$15.15
$6.12
Analyst Decision
Strong Buy
Buy
Analyst Count
5
12
Target Price
$21.50
$11.82
AVG Volume (30 Days)
190.2K
874.1K
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$818,058,000.00
$825,300,000.00
Revenue This Year
$3.97
$0.08
Revenue Next Year
$5.84
$5.28
P/E Ratio
N/A
N/A
Revenue Growth
4.31
0.21
52 Week Low
$10.24
$3.76
52 Week High
$20.48
$15.47

Technical Indicators

Market Signals
Indicator
OFIX
MYGN
Relative Strength Index (RSI) 45.02 34.22
Support Level $14.88 $6.38
Resistance Level $16.00 $6.89
Average True Range (ATR) 0.45 0.27
MACD -0.05 -0.08
Stochastic Oscillator 25.82 2.26

Price Performance

Historical Comparison
OFIX
MYGN

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: